monocrotaline and Centriacinar Emphysema

monocrotaline has been researched along with Centriacinar Emphysema in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Guan, Q; Liu, H; Liu, ZY	1

Other Studies

1 other study(ies) available for monocrotaline and Centriacinar Emphysema

Article	Year
Oral sildenafil prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats. Interactive cardiovascular and thoracic surgery, 2007, Volume: 6, Issue:5 Topics: Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Endothelin-1; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Lung Diseases, Interstitial; Male; Monocrotaline; Piperazines; Pulmonary Artery; Pulmonary Emphysema; Purines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Sildenafil Citrate; Sulfones; Time Factors; Vasodilator Agents	2007

Article

Year

Oral sildenafil prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats.

Interactive cardiovascular and thoracic surgery, 2007, Volume: 6, Issue:5

Topics: Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Endothelin-1; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Lung Diseases, Interstitial; Male; Monocrotaline; Piperazines; Pulmonary Artery; Pulmonary Emphysema; Purines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Sildenafil Citrate; Sulfones; Time Factors; Vasodilator Agents

2007